The Role of Plasma Interleukin-6 Levels on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk Scores in Javanese Patients with Chronic Kidney Disease
Authors:
- Hendri SusiloHSHendri Susilo
- Mochammad ThahaMTMochammad Thaha
- Budi Susetyo PikirBPBudi Susetyo Pikir
- Mochamad Yusuf AlsagaffMAMochamad Yusuf Alsagaff
- Satriyo Dwi SuryantoroSSSatriyo Dwi Suryantoro
- Citrawati Dyah Kencono WunguCWCitrawati Dyah Kencono Wungu
- Nando Reza PratamaNPNando Reza Pratama
- Cennikon PakpahanCPCennikon Pakpahan
- Delvac OceandyDODelvac Oceandy
Open Access
- 10 July 2022
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (7) , 1122
Abstract
Interleukin-6 (IL-6) has been identified as an important pro-inflammatory factor involved in mediating the severity of chronic kidney disease (CKD). This study sought to determine the effect of plasma IL-6 levels on atherosclerotic cardiovascular disease (ASCVD) and cardiovascular mortality risk scores in Javanese CKD patients. We also analyzed the frequency of IL-6 G174C single nucleotide polymorphism (SNP) in the population. This study was a cross-sectional study involving seventy-three patients of Javanese ethnic origin with stable chronic kidney disease. We assessed the ASCVD risk score, cardiovascular mortality score, genotyping of IL-6 G174C SNP, and plasma IL-6 levels in these patients. The genotype distribution and allele frequencies of the IL-6 G174C SNP were predominated by the G genotype/allele (GG: 97.26%, GC: 1.37%, CC: 1.37%, G-allele: 97.95%, and C-allele: 2.05%). Despite the fact that plasma IL-6 levels did not directly affect cardiovascular mortality risk, further analysis revealed its direct effect on the ASCVD risk score (path coefficient = 0.184, p = 0.043, 95% CI = 0.018–0.380), which in turn affected cardiovascular mortality risk (path coefficient = 0.851, p = <0.01, 95% CI = 0.714–0.925). In conclusion, plasma IL-6 levels play important roles on ASCVD risk and cardiovascular mortality risk in Javanese patients with CKD.Keywords
Funding Information
- Universitas Airlangga (819/UN3.15/PT/2021)
This publication has 74 references indexed in Scilit:
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice GuidelineAnnals of Internal Medicine, 2013
- Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL StudyJournal of the American Heart Association, 2013
- Estrogen, hormonal replacement therapy and cardiovascular diseaseCurrent Opinion in Nephrology and Hypertension, 2011
- -174G>C interleukin-6 gene polymorphism in Tunisian patients with coronary artery diseaseAnnals of Saudi Medicine, 2011
- Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor- are similarly associated with survival in haemodialysis patientsNephrology Dialysis Transplantation, 2010
- Serum IL-6 levels are associated with significant coronary stenosis in cardiovascularly asymptomatic inner-city black adults in the USInflammation Research, 2009
- Interleukin‐6 gene polymorphism is an age‐dependent risk factor for myocardial infarction in menInternational Journal of Immunogenetics, 2005
- Role of the Interleukin-6 −174 G>C Gene Polymorphism in Retinal Artery OcclusionStroke, 2005
- Carotid Intima-Media Thickness Is Associated With Allelic Variants of Stromelysin-1, Interleukin-6, and Hepatic Lipase GenesStroke, 2002